Hilary Sugar
Medical · Succasunna, NJNPI 1871724419
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by AbbVie at 37.9% of the total. Among medical clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 351 payments — averaging $27.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- E.r. Squibb & Sons, L.L.C.$2K
- Novartis$1K
- Amgen$1K
- Johnson & Johnson$501
- UCB, Inc.$433
- plus $684 from 10 others
What the payments were for
- Consulting fees$3,08632%
- Speaking & faculty fees$6307%
- Travel & lodging$1,08811%
- Food & beverage$4,53248%
- Education$1992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $3,609 |
| E.r. Squibb & Sons, L.L.C. | 11 | $1,731 |
| Novartis | 89 | $1,437 |
| Amgen(2 entities) | 95 | $1,141 |
| Johnson & Johnson | 37 | $501 |
| UCB, Inc. | 27 | $433 |
| AstraZeneca | 5 | $218 |
| Pfizer | 6 | $99 |
| Fresenius Kabi USA, LLC | 6 | $95 |
| Lilly USA, LLC | 6 | $88 |
| GSK | 5 | $63 |
| ANI Pharmaceuticals, Inc. | 3 | $54 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Sanofi | 1 | $18 |
| Organon | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,535 in reported general payments places this provider in the 95th percentile of 573 medical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 26 | $190,070 |
| EnbrelEtanercept | 22 | $158,071 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 18 | $155,962 |
| Humira(Cf) PenAdalimumab | 12 | $141,616 |
| Actemra ActpenTocilizumab | 13 | $61,139 |
| ProliaDenosumab | 11 | $19,202 |
| MethotrexateMethotrexate Sodium | 223 | $8,319 |
| Hydroxychloroquine Sulfate | 116 | $5,110 |
| Cevimeline Hcl | 16 | $3,903 |
| Colchicine | 17 | $3,725 |
| Prednisone | 273 | $2,254 |
| Etodolac | 51 | $1,766 |
| Risedronate Sodium | 12 | $1,712 |
| Tramadol Hcl ErTramadol Hcl | 12 | $1,545 |
| Leflunomide | 37 | $1,526 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenEnbrel, Prolia | $1,141 | $177,27333 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 573 medical providers in New Jersey.
Other medical in Succasunna
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
- Shane CourtneyLinwood$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.